跳至主要内容
临床试验/NCT05312164
NCT05312164招募中不适用

Physio-Anatomy Clinical Data Collection Study

Gentuity, LLC6 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2022年3月14日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
Gentuity, LLC
入组人数
150
试验地点
6
主要终点
Collection of angiography images, HF-OCT images, and FFR pressure wire data

研究概览

简要总结

This is an on-label clinical study design intended for the collection of three different types of interventional procedural data using FDA-cleared cardiac catheterization technologies and drugs, each used according to its product labeling and standard practice of medicine.

详细描述

These devices and drugs are commonly used for patient evaluation during PCI procedures performed by Interventional Cardiologists. The three device technologies used in a single catheterization laboratory visit for assessment of the coronary arteries include:

  • A coronary angiography imaging system to X-ray the coronary arteries for the evaluation of vessel narrowing or blocking.
  • Pressure guidewire from one or more manufacturers for the measurement of coronary physiology parameters.
  • Gentuity® HF-OCT Imaging System with Vis-Rx® Micro-Imaging catheter for imaging and sizing of the stenosed coronary arteries.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Other

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients >18 years of age.
  • Patients provide written informed consent.
  • Clinical presentation consistent with suspected coronary disease.
  • Patients who are candidates for PCI and scheduled for coronary diagnostics in the cardiac catheter lab with the intent to perform a physiological assessment for de novo lesions with stenosis, if clinically indicated.

排除标准

  • Presence of acute ST Elevation Myocardial Infarction (STEMI) at the time of the cath lab procedure.
  • Contraindication for FFR examination or administration of vasodilators.
  • Bacteremia or sepsis.
  • Major coagulation system abnormalities.
  • Severe hemodynamic instability or shock.
  • Heart Failure NYHA Class IV.
  • Severe valvular heart disease.
  • Prior heart transplant.
  • Acute renal failure based on diagnostic practice of the treating physician at time of screening.
  • Patient is pregnant.
  • Patient is currently enrolled in another clinical study that may impact the results of this study.
  • Patient has other co-morbid condition(s) that, in the opinion of the Investigator, could limit their

结局指标

主要结局

Collection of angiography images, HF-OCT images, and FFR pressure wire data

时间窗: 2 years

There are no efficacy or safety outcomes in this study. This study is a simple data collection study to help the sponsor develop next-generation HF-OCT software. Pressure wire data will be paired with HF-OCT images and angiography images for analysis to determine if the HF-OCT imaging technology can predict FFR physiology information from the OCT pullback.

次要结局

未报告次要终点

研究者

发起方
Gentuity, LLC
申办方类型
Industry
责任方
Sponsor

研究点 (6)

Loading locations...

相似试验